Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad51edabc7e68b89a389ec876664d209 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J1-0007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J1-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00 |
filingDate |
2012-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10b0afce5ff4d25f059d319600156584 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ce57fa35da82e1105d6c1e773dc5978 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be980a9d05c596832c505b9ab55f3294 |
publicationDate |
2017-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
RU-2608894-C2 |
titleOfInvention |
CRYSTALLINE FORMS OF 5α-ANDROSTANE-3β,5,6β-TRIOL AND METHODS FOR PRODUCTION THEREOF |
abstract |
FIELD: chemistry. n SUBSTANCE: present invention relates to four crystalline forms of (crystalline forms A, B, C and D) 5α-androstane-3β,5,6β-triol (YC-6) and to methods of their production. n EFFECT: said crystalline forms have better stability compared to existing forms, contain a smaller amount of impurities and are safer. n 10 cl, 12 dwg, 15 ex |
priorityDate |
2012-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |